結腸内視鏡検査装置市場 - 2030年の成長予測、統計および事実

  • Report Code : TIPRE00020478
  • Category : Medical Device
  • Status : Data Released
  • No. of Pages : 150
Buy Now

[調査レポート] 結腸内視鏡検査装置市場は、2022 年の 21 億 1,000 万米ドルから 2030 年までに 31 億 6,000 万米ドルに成長すると予測されており、2022 ~ 2030 年の間に 5.2% の CAGR を記録します。

市場洞察とアナリストの見解:

結腸内視鏡検査装置の市場予測は、この市場の利害関係者が成長戦略を計画するのに役立ちます。レポートには、結腸内視鏡検査装置市場の動向と予測期間中の予測可能な影響とともに、成長の見通しが含まれています。

結腸内視鏡検査は、再利用可能なスコープを使用して実行されます。これらは、肛門に導入され、結腸を通過する柔軟な光ファイバー器具です。結腸鏡は、内視鏡医が慢性疾患を発見し、悪性疾患や前がん性疾患がないか患者を検査するのに役立ちます。 50 歳以上の人は、定期的ながん検診計画の一環として結腸内視鏡検査を受ける必要があります。病院または外来手術センター (ASC) では、軽い鎮静下で手術が行われます。結腸直腸がんの罹患率の上昇とメーカーによる結腸内視鏡検査装置の技術進歩の増加により、結腸内視鏡検査装置の市場規模が拡大しています。しかし、直腸疾患の代替診断検査の利用可能性が市場の成長を妨げています。

成長推進要因:

結腸直腸がんの有病率の上昇が結腸内視鏡検査装置市場の成長を促進

結腸直腸がん直腸または結腸の組織に形成される悪性腫瘍です。直腸がんと結腸がんは、両方の症状に共通する特徴があるため、多くの場合グループ化されます。世界保健機関 (WHO) によると、結腸がんはがん関連死亡者数で世界第 2 位にランクされています。 2020年、全世界で新たに190万人以上が結腸直腸がんに罹患し、93万人以上が結腸直腸がんにより死亡しました。発生率と死亡率には地域ごとに大きな差がありました。ヨーロッパ、オーストラリア、ニュージーランドでは発生率が最も高く、東ヨーロッパでは致死率が最も高かったと報告されています。欧州がん情報システムが提供するデータによると、EU 27 か国では、2020 年に結腸直腸がんが新たに診断されたすべてのがんの 12.7%、結腸直腸がんによる死亡者数の 12.4% を占めました。有病率が高いため、結腸直腸がんは 2 番目に多く発生しています。欧州では乳がんに次ぐがんであり、肺がんに次ぐ第2位の死因となっている。 WHO によると、2020 年には新たに 190 万人以上の結腸直腸がん患者が発生し、結腸直腸がんの年間負担は新たに 320 万人(63% 増加)、死亡者は 160 万人(73% 増加)に増加すると予想されています。

米国では、結腸直腸がんは、毎年検出されるがんの種類の中で 3 番目に多いがん (皮膚がんを除く) です。米国癌協会によると、2023 年には国内で約 153,000 人が結腸直腸癌と診断されました。これらの数字には、新たな結腸がん症例106,950人(男性54,420人、女性52,550人)と、新たな直腸がん症例46,050人(男性27,440人、女性18,610人)が含まれます。結腸直腸がんの場合、結腸内視鏡検査は重要なスクリーニング検査であり、定期的ながん検診の一部となっています。このように、結腸直腸がんの有病率の増加が結腸内視鏡検査装置市場の成長を推進しています。

結腸内視鏡検査の代替手段には、より低侵襲性の結腸内視鏡検査であるS状結腸内視鏡検査や、非侵襲的方法の1つである便サンプル検査などがあります。 21 世紀初頭から、医師は 50 歳以上の患者に結腸がんを検査するために結腸内視鏡検査を広く推奨しています。しかし近年、彼らは戦術の変更の必要性を感じている。彼らは、結腸内視鏡検査の費用と手間がかかることを懸念しており、それが人々がこれらの検査を受けることを思いとどまらせている。さらに、結腸内視鏡検査よりも侵襲性が低く、苦痛が少ない、同様に効果的な検査が利用可能です。したがって、代替診断検査の利用可能性は、結腸内視鏡検査装置市場の成長を妨げています。



レポートの細分化と範囲:

結腸内視鏡検査装置市場分析は、以下によって実施されました。次のセグメントを考慮します: 製品タイプ、アプリケーション、エンドユーザー。

セグメント分析:

製品タイプごとに、結腸内視鏡検査デバイス市場は結腸鏡、視覚化システム、その他に分類されます。結腸内視鏡セグメントは、2022 年に最大の市場シェアを保持しました。しかし、視覚化システムセグメントは、2022 ~ 2030 年に最高の CAGR を記録すると予想されています。

製品タイプ別結腸内視鏡装置市場 – 2022 年と 2030 年
< br>結腸内視鏡検査装置市場は、用途別に結腸直腸がん、リンチ症候群、潰瘍性大腸炎、クローン病などに分類されています。結腸直腸がんセグメントは、2022 年の結腸内視鏡検査装置市場で最大のシェアを保持しており、同セグメントは 2022 年から 2030 年にかけて最高の CAGR を記録すると予想されています。結腸内視鏡検査では、悪性病変および前悪性病変を高精度で検出して除去できます。結腸直腸がんスクリーニングのための貴重な診断ツールです。ほぼすべての国内および国際的な胃腸および癌学会は、最初のスクリーニング方法としてこれを使用することを推奨しています。

結腸内視鏡検査装置市場は、エンドユーザーごとに病院、外来手術センターなどに分類されています。病院セグメントは、2022 年に結腸内視鏡検査装置市場で最大のシェアを保持し、病院における技術進歩の導入と病院での検査数の増加により、2022 ~ 2030 年にかけて最高の CAGR を記録すると予想されています。

地域分析:

結腸内視鏡検査装置市場レポートの地理的範囲には、北米、ヨーロッパ、アジア太平洋、中東とアフリカ、南米と中央アメリカが含まれます。 2022 年には北米が最大の市場シェアを獲得しました。北米の市場成長は、高齢化による負担の増大、製品発売数の増加、高度な結腸内視鏡検査装置を開発するための研究開発活動によって推進されています。

競争環境と鍵企業:

AMBU AS、Fujifilm、Endomed Systems gmbh、Olympus、Steris PLC、GI View、Boston Scientific Corporation、PENTAX Medical、Avantis Medical Systems、SonoScape Medical Corp は、結腸内視鏡検査装置で紹介されている著名な企業です。マーケットレポート。これらの企業は、世界中で高まる消費者の需要に応えるために、新技術の開発、既存製品のアップグレード、地理的プレゼンスの拡大に重点を置いています。企業のプレスリリースによると、以下に最近の主要な開発をいくつか示します。

2021 年 4 月、富士フイルム メディカル システムズは G-EYE 700 シリーズ 結腸鏡を発売しました。スマートメディカルが開発した技術「G-EYE」が日常の検査をサポートします。 G-EYE 700 シリーズ結腸鏡は、富士フイルムの革新的な結腸鏡ポートフォリオ製品を拡張しました。 G-EYEは、富士フイルムのELUXEO内視鏡ビデオイメージングシステムと互換性のある700シリーズ結腸鏡ファミリーの拡張機能として提供されます。2020年10月、オリンパスは2つの結腸内視鏡PCF-H190TとPCF-H190Tの510(k)認可を取得し、市場で入手可能になりました。 PCF-HQ190。これらの製品は、医師が胃腸管疾患を診断および治療するための現在の機能に追加機能を提供しました。
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which end user segment is dominating the colonoscopy devices market?

The colonoscopy devices market, based on end user, is segmented hospitals, ambulatory surgery centers, and others. The hospital segment held the largest colonoscopy devices market share in 2022 and is anticipated to register the highest CAGR during 2022–2030.

Which application segment is dominating the colonoscopy devices market?

The colonoscopy devices market, based on application, is segmented into colorectal cancer, lynch syndrome, ulcerative colitis, Crohn's disease, and other. The colorectal cancer segment held the largest colonoscopy devices market share in 2022, and the same segment is anticipated to register the highest CAGR during 2022–2030.

Which product type segment is dominating the colonoscopy devices market?

The colonoscopy devices market, based on product type, is segmented into colonoscope visualization systems, and others. The colonoscope segment held the largest market share in 2022. However, the visualization systems segment is anticipated to register the highest CAGR during 2022– 2030.

What is a colonoscopy device?

Colonoscopies are performed with reusable scopes. They are flexible, fiber-optic instruments that are introduced into the anus and directed through the colon. The colonoscopes helps endoscopists detect chronic illnesses and check patients for malignant or precancerous diseases. People aged 50 years and above should get colonoscopies as part of a regular cancer screening regimen. In hospitals or ambulatory surgery center (ASCs), the procedures are carried out under mild sedation.

Which region is the fastest growing the colonoscopy devices market?

Asia Pacific is expected to be the fastest-growing region in the colonoscopy devices market. The colonoscopy devices market in the region is driven by factors such as an increasing number of R&D activities, adoption of innovative technology and products, and upsurging prevalence of chronic diseases in this region.

What are the driving factors for the colonoscopy devices market across the globe?

The factors that are driving the growth of the market are the rising prevalence of colorectal cancer and increasing technological advancements in colonoscopy devices by manufacturers.

Who are the major players in the colonoscopy devices market?

The colonoscopy devices market majorly consists of players such as AMBU AS, Fujifilm, Endomed systems gmbh, Olympus, Steris PLC, GI View, Boston Scientific Corporation, PENTAX Medical, Avantis Medical Systems, and SonoScape Medical Corp among others.

Which country is dominating the colonoscopy devices market?

US holds the largest market share in colonoscopy devices market due to the increasing public awareness of colon cancer through media campaigns initiated by cancer awareness groups and government agencies, and an aging population who are encouraged to have regular checkups. According to the American Cancer Society, an estimated 104,610 new colon cancer cases and 43,340 rectal cancer cases were diagnosed in the US in 2020.

The List of Companies - Colonoscopy Devices Market

  1. AMBU AS
  2. Fujifilm
  3. Endomed systems gmbh
  4. Olympus
  5. Pentax
  6. GI View
  7. Boston Scientific Corporation
  8. Steris PLC
  9. Avantis Medical Systems
  10. SonoScape Medical Corp

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports